TABLE 2.
CVFL Sectoring Approach | Result Variable | Mild Glaucoma | Moderate Glaucoma | Severe Glaucoma |
---|---|---|---|---|
C6 (Garway-Heath) | CVFL | −1.57 ± 1.13 | −2.74 ± 3.25 | −7.30 ± 6.50 |
rCRVTL (P value) | −0.08 (.11) | −0.38 (.02*) | −0.65 (.002*) | |
rcpRNFLT (P value) | 0.05 (.36) | −0.08 (.62) | −0.13 (.56) | |
Improvement by CRVTL (LRT P value) | .08 | .01* | <.001* | |
C2 (Hood) | CVFL | −1.53 ± 1.88 | 3.51 ± 5.58 | −10.14 ± 9.80 |
rcpRNFLT (P value) | −0.14 (.008*) | 0.28 (.08) | −0.42 (.055) | |
rcpRNFLT (P value) | 0.09 (.06) | 0.04 (.78) | 0.12 (.59) | |
Improvement by CRVTL (LRT P value) | .003* | .04* | .047* |
cpRNFLT = circumpapillary retinal nerve fiber layer thickness; CRVTL = central retinal vessel trunk location; CVFL = central visual field loss; LRT = likelihood ratio test; VF = visual field.
LRT demonstrates whether adding CRVTL as additional structural parameter improves the structure-function model of the cpRNFLT–central VF association. Significant results (P < .05) are marked by asterisks. C6 and C2 refer to the 6 and 2 most central VF locations from the Garway-Heath scheme9 and the macular vulnerability zone proposed by Hood and associates,16 respectively.